Featured
-
Breaking News | Industry News
GENinCode, EVERSANA Enter Major U.S. Commercialization Pact
EVERSANA will support launch and commercialization in the U.S. market for GENinCode’s portfolio of polygenic cardiovascular disease products.06.14.21
-
Capsules | Formulation Development
Formulation of Aqueous Core Poly(lactic acid) Microcapsules
This white paper demonstrates how single-step encapsulation of a water core can be achieved using Adare Pharma Solutions' Stratμm technology.
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Yposkesi to Build Second Commercial Bioproduction Site
Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings
Novavax COVID-19 Vax is 90% Effective in Phase 3 Trial
NVX-CoV2373 demonstrates 100% protection against moderate and severe disease, 90% efficacy overall, and met the primary endpoint.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance
GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Injectables
BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
Company now supplying more than 40 countries for pandemic vaccination campaigns.06.11.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
Third milestone payment related to the development of Oral KORSUVA.06.11.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Revolo and Northway Biotech Enter Manufacturing Partnership
To manufacture novel binding immunoglobulin protein, ‘1805, to support phase 2 trials in rheumatoid arthritis and uveitis.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
WuXi XDC and LegoChem Ink ADC Agreement
Sign MOU for the development and manufacturing of antibody-drug conjugates.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Vibalogics Expands Manufacturing Capacity
Invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors.06.11.21
-
Breaking News | Cold Chain Management | Industry News | Logistics | Supply Chain
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies
Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.06.10.21
-
Biologics, Proteins, Vaccines | Industry News
Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation
Doses to be donated to approximately 100 low- and lower middle-income countries.06.10.21
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Inspections | Process Validation | Risk Management
Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates
Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.
-
Analytical Services | Bioanalytical Services | Breaking News | Facilities | Industry News | Laboratory Testing
CatSci Opens New Dagenham Laboratory
New facility is equipped with state-of-the-art analytical equipment through a collaboration with Shimadzu Corporation.06.09.21
- BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
- AGC Biologics Inks Supply Deal for COVID-19 Vaccine
- Waking from the “Coma of COVID-19”
- Waving Goodbye to Human Clinical Trials in a Post-COVID Landscape
- Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine
- CPL Completes Successful Virtual Health Canada Audit
- Samsung Biologics Expands Vaccine Manufacturing Capabilities
- Resilience Bolsters Canadian Biomanufacturing Site
- Humanigen Selects Chime Biologics as Manufacturing Partner
- FDA Expands EUA for Pfizer, BioNTech’s Covid-19 Vax
- GENinCode, EVERSANA Enter Major U.S. Commercialization Pact
- Yposkesi to Build Second Commercial Bioproduction Site
- Novavax COVID-19 Vax is 90% Effective in Phase 3 Trial
- iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance
- BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
- Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
- Revolo and Northway Biotech Enter Manufacturing Partnership
- WuXi XDC and LegoChem Ink ADC Agreement
- Vibalogics Expands Manufacturing Capacity
- Emirates SkyCargo Expands Pharma Cool Chain Capabilities
June 2021
- CRO Industry Update
- Preparing for Preclinical Testing: A Readiness Checklist
- Strategies for Entering Phase 1 Clinical Development with Limited API
- Meeting with the FDA: Valuing the Statistician and Preparation for Review
- CEO Spotlight: Patrick Haffey, Selkirk
- Biocatalysis: An Indispensable Tool for API Synthesis
- Addressing the Need for Standards in Cell and Gene Therapy
- Adapting Manufacturing for Super Small Batch, Precision Medicines
- 22nd Annual Salary Survey
- Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm
Contract Service Directory
Search the Directories for A Company:
